封面
市場調查報告書
商品編碼
2020730

2026-2034年全球醫療保健電子同意市場規模、佔有率、趨勢和成長分析報告

Global eConsent In Healthcare Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計醫療保健領域的電子同意市場將從 2025 年的 5.8277 億美元成長到 2034 年的 14.62 億美元,2026 年至 2034 年的複合年成長率為 10.76%。

隨著醫療服務提供者擴大採用數位化解決方案來簡化患者知情同意流程,全球醫療保健領域的電子知情同意市場正在快速成長。電子知情同意平台允許患者以電子方式查看和簽署知情同意書,從而提高醫療程序的效率和透明度。醫療保健系統數位轉型的推進是推動市場成長的主要動力。

電子健康記錄和臨床研究平台的日益普及也推動了電子知情同意解決方案的採用。這些系統有助於加深患者對醫療程序的參與和理解,同時確保符合監管要求。製藥公司和臨床研究機構正在臨床試驗中廣泛應用電子知情同意技術。

隨著醫療機構持續增加對數位醫療技術的投入,預計市場將顯著擴張。雲端運算、資料安全和行動醫療平台的進步將進一步提升電子知情同意解決方案的有效性。對以病人為中心的醫療保健和監管合規性的日益重視也將繼續推動市場發展。

目錄

第1章:引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章:全球醫療保健電子知情同意市場:依部署模式分類

  • 市場分析、洞察與預測
  • 基於雲端的
  • 現場

第5章:全球醫療保健電子同意市場:按應用領域分類

  • 市場分析、洞察與預測
  • 臨床試驗
  • 治療同意書
  • 遠端醫療

第6章:全球醫療保健電子知情同意市場:依工作流程整合分類

  • 市場分析、洞察與預測
  • 整合解決方案
  • 獨立解決方案

第7章:全球醫療保健電子同意市場:依使用者介面分類

  • 市場分析、洞察與預測
  • 網路為基礎的平台
  • 行動應用

第8章:全球醫療保健電子同意市場:依最終用途分類

  • 市場分析、洞察與預測
  • 臨床研究機構
  • 醫院和診所
  • 製藥和生物技術公司
  • 其他最終用戶

第9章:全球醫療保健電子知情同意市場:按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第10章 競爭格局

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴(根據現有資訊)
  • 市場佔有率和市場定位分析(基於現有資訊)
  • 供應商情況(基於現有資訊)
  • 策略規劃

第11章:公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Advarra
    • Calysta EM
    • Castor
    • Climedo Health GmbH
    • Clinical Ink
    • Concentric Health Ltd
    • Epic Communications
    • EvidentIQ Group GmbH
    • Florence Healthcare
    • Interlace Health
    • IQVIA
    • Obvio Health USA Inc
    • Signant Health
    • Suvoda LLC
    • Veeva Systems
簡介目錄
Product Code: VMR112117923

The eConsent In Healthcare Market size is expected to reach USD 1462.00 Million in 2034 from USD 582.77 Million (2025) growing at a CAGR of 10.76% during 2026-2034.

The global eConsent in healthcare market is growing rapidly as healthcare providers increasingly adopt digital solutions to streamline patient consent processes. eConsent platforms enable patients to review and sign consent forms electronically, improving efficiency and transparency in healthcare procedures. The growing digital transformation of healthcare systems is a major driver of market growth.

The increasing use of electronic health records and clinical research platforms is also encouraging the adoption of eConsent solutions. These systems help ensure regulatory compliance while improving patient engagement and understanding of medical procedures. Pharmaceutical companies and clinical research organizations are widely adopting eConsent technologies in clinical trials.

Looking forward, the market is expected to expand significantly as healthcare institutions continue to invest in digital health technologies. Advances in cloud computing, data security, and mobile healthcare platforms will further enhance eConsent solutions. The growing emphasis on patient-centered healthcare and regulatory compliance will continue to support market development.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Deployment Mode

  • Cloud-Based
  • On-Premises

By Application

  • Clinical Trials
  • Treatment Consent
  • Telemedicine

By Workflow Integration

  • Integrated Solutions
  • Standalone Solutions

By User Interface

  • Web-Based Platforms
  • Mobile Applications

By End-Use

  • Clinical Research Organizations
  • Hospitals And Clinics
  • Pharmaceutical And Biotech Companies
  • Other End-Users

COMPANIES PROFILED

  • Advarra, Calysta EM, Castor, Climedo Health GmbH, Clinical ink, Concentric Health Ltd, Epic Communications, EvidentIQ Group GmbH, Florence Healthcare, Interlace Health, IQVIA, Obvio Health USA Inc, Signant Health, Suvoda LLC, Veeva Systems
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL ECONSENT IN HEALTHCARE MARKET: BY DEPLOYMENT MODE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Deployment Mode
  • 4.2. Cloud-Based Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. On-Premises Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ECONSENT IN HEALTHCARE MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Clinical Trials Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Treatment Consent Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Telemedicine Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ECONSENT IN HEALTHCARE MARKET: BY WORKFLOW INTEGRATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Workflow Integration
  • 6.2. Integrated Solutions Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Standalone Solutions Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ECONSENT IN HEALTHCARE MARKET: BY USER INTERFACE 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast User Interface
  • 7.2. Web-Based Platforms Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Mobile Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL ECONSENT IN HEALTHCARE MARKET: BY END-USE 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast End-use
  • 8.2. Clinical Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Hospitals And Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.4. Pharmaceutical And Biotech Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.5. Other End-Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL ECONSENT IN HEALTHCARE MARKET: BY REGION 2022-2034 (USD MN)

  • 9.1. Regional Outlook
  • 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.2.1 By Deployment Mode
    • 9.2.2 By Application
    • 9.2.3 By Workflow Integration
    • 9.2.4 By User Interface
    • 9.2.5 By End-use
    • 9.2.6 United States
    • 9.2.7 Canada
    • 9.2.8 Mexico
  • 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.3.1 By Deployment Mode
    • 9.3.2 By Application
    • 9.3.3 By Workflow Integration
    • 9.3.4 By User Interface
    • 9.3.5 By End-use
    • 9.3.6 United Kingdom
    • 9.3.7 France
    • 9.3.8 Germany
    • 9.3.9 Italy
    • 9.3.10 Russia
    • 9.3.11 Rest Of Europe
  • 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.4.1 By Deployment Mode
    • 9.4.2 By Application
    • 9.4.3 By Workflow Integration
    • 9.4.4 By User Interface
    • 9.4.5 By End-use
    • 9.4.6 India
    • 9.4.7 Japan
    • 9.4.8 South Korea
    • 9.4.9 Australia
    • 9.4.10 South East Asia
    • 9.4.11 Rest Of Asia Pacific
  • 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.5.1 By Deployment Mode
    • 9.5.2 By Application
    • 9.5.3 By Workflow Integration
    • 9.5.4 By User Interface
    • 9.5.5 By End-use
    • 9.5.6 Brazil
    • 9.5.7 Argentina
    • 9.5.8 Peru
    • 9.5.9 Chile
    • 9.5.10 Rest of Latin America
  • 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.6.1 By Deployment Mode
    • 9.6.2 By Application
    • 9.6.3 By Workflow Integration
    • 9.6.4 By User Interface
    • 9.6.5 By End-use
    • 9.6.6 Saudi Arabia
    • 9.6.7 UAE
    • 9.6.8 Israel
    • 9.6.9 South Africa
    • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

  • 10.1. Recent Developments
  • 10.2. Company Categorization
  • 10.3. Supply Chain & Channel Partners (based on availability)
  • 10.4. Market Share & Positioning Analysis (based on availability)
  • 10.5. Vendor Landscape (based on availability)
  • 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL ECONSENT IN HEALTHCARE INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Company Profiles
    • 11.2.1 Advarra
    • 11.2.2 Calysta EM
    • 11.2.3 Castor
    • 11.2.4 Climedo Health GmbH
    • 11.2.5 Clinical Ink
    • 11.2.6 Concentric Health Ltd
    • 11.2.7 Epic Communications
    • 11.2.8 EvidentIQ Group GmbH
    • 11.2.9 Florence Healthcare
    • 11.2.10 Interlace Health
    • 11.2.11 IQVIA
    • 11.2.12 Obvio Health USA Inc
    • 11.2.13 Signant Health
    • 11.2.14 Suvoda LLC
    • 11.2.15 Veeva Systems